People seek ways to pause a difficult psychedelic experience. Psychedelic Science Review spotlights ketanserin’s promise. Here’s what’s known, what isn’t, and harm-reduction context for DMV readers.

A closed-door, two-day SAMHSA consultation in Washington, DC convened federal reps, researchers, regulators, and entrepreneurs to tackle psychedelic data gaps—no drug developers invited.

NORML reports an association between medical cannabis access laws and gains in workplace productivity and innovation. Here’s what that could mean for DMV residents and delivery compliance.

From a Republican governor’s commission to an anthropologist’s testimony and a San Francisco organizer, these figures still shape today’s debates on delivery, access and compliance.

Filmmaker-novelist Lindsay Kent uses a crime thriller to probe consciousness, identity, and power—showing how fiction can shape real debates in the DMV.

An Arizona-based MSO paused operations at an Ohio cannabis store after state regulators began investigating at least two serious adverse health events tied to suspected customers.